1-3 of 3
Sisse Rye Ostrowski, MD, PhD, DMSc
Close
Sort by
Journal Articles

Pre-Transplantation ST2 Levels and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation

Lars Klingen Gjærde, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Niels Smedegaard Andersen, MD PhD DMSc, Lone Smidstrup Friis, MD PhD, Brian Kornblit, MD PhD, Søren Lykke Petersen, MD DMSc, Ida Schjødt, MD PhD, Henrik Sengeløv, MD DMSc, Prof
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-133876
Published: 2020
Journal Articles

Combined Ibrutinib and Venetoclax Changes Myeloid Phenotype and Improves Immune Function in CLL Patients

Rebecka Svanberg, MD, Sisse Rye Ostrowski, MD PhD DMSc, Ass Prof, Jakob Thaning Bay, MD PhD, Lars Peter Ryder, MSc, PhD, Hanne Vibeke Vibeke Marquart, Arnon P Kater, MD PhD, Carsten Utoft Niemann, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4289.
https://doi.org/10.1182/blood-2019-123410
Published: 2019
Journal Articles

Endothelial Glycocalyx Degradation Is Associated with Bleeding, Thrombocytopathy, Endothelial Disruption and Leukocytosis in Acute Myeloid Leukemia.

Anne Mette Larsen, MD, Eva Birgitte Leinøe, MD, PhD, Pär Johansson, MD, DMSc, Henrik Birgens, MD, DMSc, Sisse Rye Ostrowski, MD, PhD, DMSc
Journal: Blood
Blood (2012) 120 (21): 2173.
https://doi.org/10.1182/blood.V120.21.2173.2173
Published: 2012